Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

December 7, 2021

Drosophila as a model to study autophagy in neurodegenerative diseases and digestive tract.

IUBMB Life
Fei-Yang TzouChih-Chiang Chan
December 7, 2021
Review

Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer.

American Journal of Cancer Research
Neelum Aziz YousafzaiXian Wang
December 7, 2021
Open Access

The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells.

Scientific Reports
Tin Myo KhingUy Dong Sohn
December 7, 2021

A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease.

CNS & Neurological Disorders Drug Targets
Ozlem Bahadır AcıkaraHamid Reza Khayat Kashani
December 6, 2021

An unexpected tumor suppressor role of SQSTM1/p62 in liver tumorigenesis.

Autophagy
Xiaojuan ChaoWen-Xing Ding
December 6, 2021
Open Access

Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.

Frontiers in Cell and Developmental Biology
Meng-Yu ZhangYi-Qing Qu
December 6, 2021
Open Access

Autophagy Regulates VDAC3 Ubiquitination by FBXW7 to Promote Erastin-Induced Ferroptosis in Acute Lymphoblastic Leukemia.

Frontiers in Cell and Developmental Biology
Ting ZhuYang Fan
December 6, 2021
Open Access

Targeting ERK induced cell death and p53/ROS-dependent protective autophagy in colorectal cancer.

Cell Death Discovery
Wunan MiYang Fu
December 6, 2021

Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells.

Biochemical Pharmacology
Liang-Jun WangLong-Sen Chang
December 4, 2021
Preprint
Open Access

Spatially Resolved Phosphoproteomics Reveals Fibroblast Growth Factor Receptor Recycling-driven Regulation of Autophagy and Survival

BioRxiv : the Preprint Server for Biology
J. WatsonChiara Francavilla
December 4, 2021

Arsenite-induced cytotoxicity is regulated by p38-SQSTM1/p62 and JNK-BNIP3L/Nix signaling in lung cancer cells.

Biochemical and Biophysical Research Communications
Hyun-Young Lee, Seon-Hee Oh

Sign up to follow this feed and discover related papers.

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Antibody Therapeutics (MDS)

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. They have also been detected in several other neurodegenerative diseases, known as synucleopathies. Here is the latest research on alpha-synuclein antibody therapeutics.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Brain Imaging of Neural Circuits (MDS)

Neural circuits are groups of interconnected neurons which carry out specific functions when activated. Imaging these neural circuits allows researches to further elucidate their mechanisms and functions. Follow this feed to stay up to date on brain imaging of neural circuits.

Cervical Dystonia (MDS)

Cervical dystonia, or spasmodic torticollis, is a neurological disorder in which involuntary muscle contractions in the neck cause abnormal head and neck movements. Current treatment options include botulinum toxin injections, oral medications, and surgery. Find the latest research on cervical dystonia here.

Childhood Movement Disorders (MDS)

Children with movement disorders display unwanted movements or have difficulties moving in the way they intend to. Most childhood movement disorders are rare; they can result from different types of brain injury, infection or other causes such as genetic disorders. This feed covers research into tremor, dystonia, chorea, ataxia and other movement disorders specifically in children.

Chorea (MDS)

Chorea is a movement disorder characterized by brief, involuntary, irregular contractions. The contractions appear to flow across adjacent muscles. Chorea may be due to neurodegenerative disorders, structural brain damage, or autoimmune diseases. Find the latest research on chorea here.

© 2021 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-autophagy-mds/1d3502b2-acca-4849-ae75-f467f043eef9